Qing Xu
- Molecular Biology top 5%
- Oncology top 2%
- Cancer Research top 2%
- Pulmonary and Respiratory Medicine top 2%
- Immunology top 5%
- Topics
- Cancer Immunotherapy and Biomarkers (13 papers)CAR-T cell therapy research (11 papers)Immunotherapy and Immune Responses (11 papers)
- Journals
- Nucleic Acids ResearchJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Qing Xu
169 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Molecular Biology 2.0k
- Oncology 1.5k
- Cancer Research 1.0k
- Pulmonary and Respiratory Medicine 876
- Immunology 556
Countries citing papers authored by Qing Xu
This map shows the geographic impact of Qing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Xu more than expected).
Fields of papers citing papers by Qing Xu
This network shows the impact of papers produced by Qing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Xu. The network helps show where Qing Xu may publish in the future.
Co-authorship network of co-authors of Qing Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Qing Xu. A scholar is included among the top collaborators of Qing Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Xu. Qing Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 6 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 54 | |
| 8 | 32 | |
| 9 | 6 | |
| 10 | 14 | |
| 11 | 9 | |
| 12 | 15 | |
| 13 | 7 | |
| 14 | 36 | |
| 15 | 17 | |
| 16 | 9 | |
| 17 | 1 | |
| 18 | 6 | |
| 19 | [Preparation of senkyunolide I by reversed-phase high performance liquid chromatography]. | 2 |
| 20 | 28 |
About Qing Xu
Qing Xu is a scholar working on Oncology, Cancer Research and Immunology, having authored 182 papers that have together received 4.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (13 papers), CAR-T cell therapy research (11 papers) and Immunotherapy and Immune Responses (11 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.5k citations) and Molecular Biology (2.0k citations). Qing Xu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Min Yuan, Jie Wu, Jianhua Chen, Lili Huang, Juemin Fang, Ran Cui, Zhuqing Liu, Xianling Guo, Hua Yu and Jin Cheng. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.